Purchase Order 75N93018P01009

The Department of Health and Human Services Food and Drug Administration awarded a $40,000 firm fixed price delivery order against its IDIQ contract for Proteomics of Human Plasma and/or Serum. Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc., will provide plasma proteomic assay services per sample under the terms of this order. Performance will take place in Silver Spring, Maryland through August 31, 2022. No set-aside designation was applied to this award made in...

The Department of Health and Human Services Food and Drug Administration awarded a $87,620 purchase order to Olink Proteomics Inc. of Waltham, Massachusetts. The firm fixed price contract is for quantitative proteomics measurement of 100 human COVID-19 plasma samples. Performance will take place in Waltham from July 18, 2023 through December 8, 2023. The solicitation sought quantitative proteomics measurement of the specified plasma samples, as described in the attached combined synopsis and...

The U.S. Food and Drug Administration (FDA) awarded a $106,675.00 firm fixed-price purchase order contract to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company, for a proteomic analysis of cancer patient plasma samples. The contract, which has no set-aside designation, will be performed at Olink's facility in Waltham, Massachusetts and involves the comprehensive analysis of over 5,000 proteins across 100 plasma samples using Olink's advanced multiplex immunoassay...

The Department of Veterans Affairs Veterans Health Administration awarded a $498,570 firm fixed price purchase order to Olink Proteomics AB of Palo Alto, California. The contract is for proteomics analysis services of between 500-1000 human plasma samples derived from peripheral blood using EDTA. The samples will be sent from the MAVERIC Biorepository in Boston or another VA biorepository to Olink's facility for analysis over the one-year period of performance from September 2020 through...

<p>This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to Bioproximity LLC, a for-profit limited liability company, for global proteomic profiling sample preparation and data services. The contract has a ceiling value of $89,100.00 and an ultimate completion date of August 2, 2016. This contract award is not associated with a larger vehicle and does not have a set-aside designation.</p>

The U.S. Food and Drug Administration (FDA) awarded a $99,413.00 firm-fixed-price purchase order contract to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company, to conduct cardiotoxicity biomarker analysis on plasma samples from cancer patients. The contract has an ultimate completion date of September 29, 2025. This contract was awarded under a competitive solicitation that was set aside for small businesses under NAICS code 541380 - Testing Laboratories and Services....

The Food and Drug Administration (FDA) awarded a $94,500 firm fixed-price purchase order to Olink Proteomics AB, a foreign-owned manufacturer of protein biomarker analysis technologies and services. The contract is for quantitative proteomics measurement of cardiotoxicity biomarkers in 150 human plasma samples using Olink's proprietary Explore 1536 multiplex analysis platform. This purchase order was awarded without a set-aside and is not associated with a larger contract vehicle. Olink...

This task order, awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA), calls for $470,000 in proteomics analysis services of human serum or plasma from Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc. The firm fixed price delivery order has a period of performance through August 31, 2022 and was awarded on September 30, 2020 without a set-aside designation. The place of performance will be Silver Spring, Maryland, where the HHS...

This federal contract award, valued at $24,775.29, was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company located in Waltham, Massachusetts. The contract requires Olink to provide proteomic kits to isolate and quantify proteins in plasma and bronchiole alveolar lavage samples. This is a firm fixed-price purchase order contract with a completion...

The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a firm-fixed price purchase order contract to Olink Proteomics Inc. for $115,920.00 to provide protein biomarker analysis of cardiotoxicity in human plasma samples. The contract has a completion date of December 31, 2022 and was awarded on June 9, 2022. No set-aside designation was used for this award. Olink Proteomics is a biotechnology company that specializes in proteomics solutions and has held...